A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations
- 1 May 1989
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 97 (5) , 785-797
- https://doi.org/10.1016/s0022-5223(19)34525-8
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Transmission of the Human Immunodeficiency VirusNew England Journal of Medicine, 1987
- Intracranial Bleeding during Treatment with Hydroxyethyl StarchNew England Journal of Medicine, 1987
- Selecting the optimal dose of low‐molecular‐weight hydroxyethyl starch (Pentastarch) for granulocyte collectionTransfusion, 1987
- Intraoperative allergic reactions to hydroxyethyl starch: A report of two casesCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1986
- Effects of hydroxyethyl starch on blood coagulation, particularly factor VIIITransfusion, 1985
- Rewarming hypovolemia after aortocoronary bypass surgeryCritical Care Medicine, 1984
- Hydroxyethyl Starch versus Albumin for Colloid Infusion Following Cardiopulmonary Bypass in Patients Undergoing Myocardial RevascularizationThe Annals of Thoracic Surgery, 1984
- Extracellular fluid volume expansion and third space sequestration at the site of small bowel anastomosesBritish Journal of Surgery, 1983
- Clinical Comparison of Hetastarch and Albumin in Postoperative Cardiac PatientsThe Annals of Thoracic Surgery, 1982
- Pharmacokinetics of Hydroxyethyl Starch in Normal SubjectsThe Journal of Clinical Pharmacology, 1982